Barclays Raises Procter & Gamble (NYSE:PG) Price Target to $170.00

Procter & Gamble (NYSE:PG) had its price objective lifted by analysts at Barclays from $168.00 to $170.00 in a note issued to investors on Tuesday, Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Barclays‘s price objective would suggest a potential upside of 5.56% from the company’s previous close.

A number of other equities research analysts have also commented on the company. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a research report on Thursday, February 29th. Jefferies Financial Group boosted their target price on shares of Procter & Gamble from $175.00 to $182.00 and gave the stock a “buy” rating in a research note on Monday. Royal Bank of Canada upped their price target on shares of Procter & Gamble from $156.00 to $157.00 and gave the company a “sector perform” rating in a research report on Wednesday, January 24th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of Procter & Gamble from $172.00 to $171.00 and set a “buy” rating for the company in a research note on Monday. Finally, Stifel Nicolaus lifted their price objective on shares of Procter & Gamble from $155.00 to $157.00 and gave the company a “hold” rating in a research note on Wednesday, January 24th. Seven analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $168.88.

Procter & Gamble Trading Up 0.3 %

Shares of Procter & Gamble stock traded up $0.50 during trading hours on Tuesday, reaching $161.04. The stock had a trading volume of 2,059,832 shares, compared to its average volume of 6,893,167. The firm has a market capitalization of $378.93 billion, a price-to-earnings ratio of 26.33, a P/E/G ratio of 3.19 and a beta of 0.44. The company has a current ratio of 0.69, a quick ratio of 0.48 and a debt-to-equity ratio of 0.48. Procter & Gamble has a 1 year low of $141.45 and a 1 year high of $163.14. The firm has a 50 day simple moving average of $159.21 and a two-hundred day simple moving average of $153.13.

Procter & Gamble (NYSE:PG) last announced its earnings results on Friday, April 19th. The company reported $1.52 earnings per share for the quarter, beating the consensus estimate of $1.42 by $0.10. The firm had revenue of $20.20 billion for the quarter, compared to the consensus estimate of $20.43 billion. Procter & Gamble had a return on equity of 33.77% and a net margin of 18.00%. The firm’s revenue for the quarter was up .6% on a year-over-year basis. During the same quarter in the previous year, the business earned $1.37 EPS. As a group, equities research analysts anticipate that Procter & Gamble will post 6.53 earnings per share for the current year.

Insiders Place Their Bets

In related news, CEO R. Alexandra Keith sold 776 shares of Procter & Gamble stock in a transaction on Monday, March 4th. The shares were sold at an average price of $158.11, for a total transaction of $122,693.36. Following the transaction, the chief executive officer now owns 4,859 shares in the company, valued at approximately $768,256.49. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In other Procter & Gamble news, CEO R. Alexandra Keith sold 776 shares of the company’s stock in a transaction dated Monday, March 4th. The shares were sold at an average price of $158.11, for a total value of $122,693.36. Following the transaction, the chief executive officer now directly owns 4,859 shares in the company, valued at approximately $768,256.49. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Gary A. Coombe sold 22,000 shares of the stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $161.32, for a total transaction of $3,549,040.00. Following the transaction, the chief executive officer now owns 36,845 shares in the company, valued at $5,943,835.40. The disclosure for this sale can be found here. In the last quarter, insiders sold 279,063 shares of company stock valued at $43,187,745. Company insiders own 0.17% of the company’s stock.

Hedge Funds Weigh In On Procter & Gamble

Institutional investors have recently bought and sold shares of the company. Cardinal Capital Management grew its holdings in shares of Procter & Gamble by 1.0% in the third quarter. Cardinal Capital Management now owns 48,489 shares of the company’s stock valued at $7,073,000 after purchasing an additional 494 shares in the last quarter. Altus Wealth Management LLC raised its position in Procter & Gamble by 0.5% in the 3rd quarter. Altus Wealth Management LLC now owns 30,579 shares of the company’s stock valued at $4,460,000 after purchasing an additional 144 shares during the last quarter. First Affirmative Financial Network raised its position in Procter & Gamble by 21.3% in the 3rd quarter. First Affirmative Financial Network now owns 5,103 shares of the company’s stock valued at $744,000 after purchasing an additional 895 shares during the last quarter. Bridge Creek Capital Management LLC raised its position in Procter & Gamble by 1.0% during the 3rd quarter. Bridge Creek Capital Management LLC now owns 42,367 shares of the company’s stock worth $6,180,000 after buying an additional 437 shares during the last quarter. Finally, Buttonwood Financial Advisors Inc. raised its position in Procter & Gamble by 3.4% during the 3rd quarter. Buttonwood Financial Advisors Inc. now owns 9,765 shares of the company’s stock worth $1,424,000 after buying an additional 322 shares during the last quarter. 65.77% of the stock is owned by hedge funds and other institutional investors.

Procter & Gamble Company Profile

The Procter & Gamble Company provides branded consumer packaged goods worldwide. It operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, and SK-II brands.